Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial
- PMID: 40462189
- PMCID: PMC12135476
- DOI: 10.1186/s13045-025-01714-1
Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial
Erratum for
-
BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial.J Hematol Oncol. 2025 May 19;18(1):56. doi: 10.1186/s13045-025-01713-2. J Hematol Oncol. 2025. PMID: 40383818 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
